Jane Street’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $117M | Buy |
1,859,600
+423,600
| +29% | +$33.9M | 0.02% | 574 |
|
|
2025
Q4 | $137M | Buy |
1,436,000
+794,300
| +124% | +$77.9M | 0.02% | 464 |
|
|
2025
Q3 | $62.6M | Buy |
641,700
+48,700
| +8% | +$5.04M | 0.01% | 832 |
|
|
2025
Q2 | $63.7M | Sell |
593,000
-326,300
| -35% | -$33M | 0.01% | 642 |
|
|
2025
Q1 | $92.7M | Buy |
919,300
+323,700
| +54% | +$32.6M | 0.02% | 411 |
|
|
2024
Q4 | $53.2M | Buy |
595,600
+115,500
| +24% | +$10.2M | 0.01% | 673 |
|
|
2024
Q3 | $40.2M | Sell |
480,100
-149,200
| -24% | -$11.8M | 0.01% | 790 |
|
|
2024
Q2 | $48.5M | Buy |
629,300
+420,600
| +202% | +$30.8M | 0.01% | 704 |
|
|
2024
Q1 | $14.3M | Sell |
208,700
-208,600
| -50% | -$13.4M | ﹤0.01% | 1477 |
|
|
2023
Q4 | $24.1M | Buy |
417,300
+5,100
| +1% | +$272K | 0.01% | 1119 |
|
|
2023
Q3 | $21.8M | Buy |
412,200
+300,500
| +269% | +$15.8M | 0.01% | 1032 |
|
|
2023
Q2 | $6.04M | Sell |
111,700
-53,300
| -32% | -$2.78M | ﹤0.01% | 2485 |
|
|
2023
Q1 | $8.25M | Sell |
165,000
-241,600
| -59% | -$11.4M | ﹤0.01% | 1832 |
|
|
2022
Q4 | $18.8M | Sell |
406,600
-21,800
| -5% | -$944K | 0.01% | 1062 |
|
|
2022
Q3 | $16.6M | Sell |
428,400
-60,300
| -12% | -$2.42M | 0.01% | 1234 |
|
|
2022
Q2 | $18.2M | Buy |
488,700
+140,200
| +40% | +$5.71M | 0.01% | 1190 |
|
|
2022
Q1 | $15.4M | Buy |
348,500
+147,000
| +73% | +$6.37M | 0.01% | 1508 |
|
|
2021
Q4 | $8.56M | Sell |
201,500
-417,900
| -67% | -$17.6M | ﹤0.01% | 2073 |
|
|
2021
Q3 | $26.9M | Buy |
619,400
+282,500
| +84% | +$12.5M | 0.01% | 937 |
|
|
2021
Q2 | $14.4M | Buy |
336,900
+269,200
| +398% | +$11.3M | 0.01% | 1352 |
|
|
2021
Q1 | $2.62M | Sell |
67,700
-170,900
| -72% | -$6.47M | ﹤0.01% | 3518 |
|
|
2020
Q4 | $8.58M | Buy |
238,600
+109,000
| +84% | +$3.93M | ﹤0.01% | 1557 |
|
|
2020
Q3 | $4.95M | Sell |
129,600
-383,300
| -75% | -$14.8M | ﹤0.01% | 1858 |
|
|
2020
Q2 | $18M | Buy |
512,900
+429,200
| +513% | +$15.5M | 0.01% | 809 |
|
|
2020
Q1 | $2.73M | Sell |
83,700
-14,400
| -15% | -$563K | ﹤0.01% | 1709 |
|
|
2019
Q4 | $4.44M | Sell |
98,100
-73,000
| -43% | -$3.05M | 0.01% | 1191 |
|
|
2019
Q3 | $6.96M | Sell |
171,100
-10,900
| -6% | -$462K | 0.01% | 772 |
|
|
2019
Q2 | $7.82M | Sell |
182,000
-8,600
| -5% | -$331K | 0.01% | 764 |
|
|
2019
Q1 | $7.32M | Buy |
190,600
+47,700
| +33% | +$1.82M | 0.01% | 878 |
|
|
2018
Q4 | $5.05M | Sell |
142,900
-632,800
| -82% | -$23M | 0.01% | 946 |
|
|
2018
Q3 | $29.9M | Buy |
775,700
+246,300
| +47% | +$8.6M | 0.06% | 241 |
|
|
2018
Q2 | $17.3M | Buy |
529,400
+516,900
| +4,135% | +$15.6M | 0.04% | 358 |
|
|
2018
Q1 | $342K | Buy |
+12,500
| New | +$340K | ﹤0.01% | 3878 |
|
|
2017
Q3 | – | Sell |
-41,000
| Closed | -$1.14M | – | 4462 |
|
|
2017
Q2 | $1.14M | Buy |
+41,000
| New | +$1.09M | ﹤0.01% | 2072 |
|
|
2016
Q3 | – | Sell |
-19,800
| Closed | -$463K | – | 3999 |
|
|
2016
Q2 | $463K | Buy |
19,800
+7,800
| +65% | +$169K | ﹤0.01% | 2846 |
|
|
2016
Q1 | $226K | Buy |
+12,000
| New | +$211K | ﹤0.01% | 3558 |
|
|
2015
Q2 | – | Sell |
-104,100
| Closed | -$1.85M | – | 3633 |
|
|
2015
Q1 | $1.85M | Buy |
+104,100
| New | +$1.65M | 0.01% | 922 |
|
Other funds holding BSX
VCM
VPM
Jane Street's BSX Position: Q1 2026 in Review
Jane Street increased its Boston Scientific (BSX) stake by 6.3% in Q1 2026, buying an estimated $19.1M and bringing the position to 4,032,117 shares worth $253M. The position accounts for 0.03% of the portfolio, ranked #330.
Jane Street first reported a position in BSX in Q2 2013 and has held it in 46 quarters since. The position peaked at $362M in Q4 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Jane Street held 4,032,117 shares of Boston Scientific worth $253M as of Q1 2026.
- Jane Street bought 238,881 Boston Scientific shares in Q1 2026, an estimated $19.1M.
- Boston Scientific made up 0.03% of Jane Street's portfolio in Q1 2026, its #330 holding.
- Jane Street first reported a position in Boston Scientific in Q2 2013 and has held it in 46 quarters since.
- Jane Street's Boston Scientific position peaked at $362M in Q4 2025.
- 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.